Industrial sector

Espoir Biosciences

Espoir Biosciences is a biotechnology company dedicated to developing innovative therapies designed to stimulate axonal regeneration and repair in neurodegenerative diseases. The company is developing a portfolio of antisense oligonucleotides (ASOs) based on high-potential, first-in-class therapeutic targets. Its lead program targets amyotrophic lateral sclerosis (ALS), with potential for expansion into Parkinson’s disease and Huntington’s disease.

https://espoir.bio/
https://www.linkedin.com/company/espoir-biosciences/

Stay up to date with the latest news on RNA therapies